This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: National Research Council of Canada. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Cunle Wu: Innovator in Antigen-Binding Agents
Introduction
Cunle Wu is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of antigen-binding agents. With a total of 3 patents, his work has the potential to impact therapeutic strategies in cancer treatment.
Latest Patents
Cunle Wu's latest patents include groundbreaking innovations such as "Antigen-Binding Agents That Specifically Bind Epidermal Growth Factor Receptor Variant III" and "Anti-EGFRVIII Antibodies and Antigen-Binding Fragments Thereof." These patents reflect his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Cunle Wu is affiliated with the National Research Council of Canada, where he conducts research that bridges the gap between scientific discovery and practical application. His work is characterized by a focus on developing targeted therapies that can effectively address complex medical challenges.
Collaborations
Cunle has collaborated with esteemed colleagues such as Anne Marcil and Traian Sulea. These partnerships enhance the scope and impact of his research, fostering an environment of innovation and shared knowledge.
Conclusion
Cunle Wu's contributions to the field of antigen-binding agents exemplify the spirit of innovation in biomedical research. His patents and collaborations position him as a key figure in the ongoing quest for effective cancer therapies.